Drug Shortage Report for TARO-TEMOZOLOMIDE

Last updated on 2018-08-03 History
Report ID 182
Drug Identification Number 02443554
Brand name TARO-TEMOZOLOMIDE
Common or Proper name TEMOZOLOMIDE
Company Name TARO PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) TEMOZOLOMIDE
Strength(s) 250MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 5 blister
ATC code L01AX
ATC description ALKYLATINGAGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-01-18
Estimated end date 2018-07-07
Actual end date 2018-08-02
Shortage status Resolved
Updated date 2018-08-03
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 130 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v39 2018-08-03 French Compare
v38 2018-08-03 English Compare
v37 2018-06-15 French Compare
v36 2018-06-15 English Compare
v35 2018-05-25 French Compare
v34 2018-05-25 English Compare
v33 2018-04-27 French Compare
v32 2018-04-27 English Compare
v31 2018-04-13 French Compare
v30 2018-04-13 English Compare
v29 2018-03-16 French Compare
v28 2018-03-16 English Compare
v27 2018-03-05 French Compare
v26 2018-03-05 French Compare
v25 2018-03-05 English Compare
v24 2018-02-23 French Compare
v23 2018-02-23 English Compare
v22 2018-02-02 French Compare
v21 2018-02-02 English Compare
v20 2018-01-19 French Compare

Showing 1 to 20 of 39